FDA lax in drug safety, journal warns

Here is another reason not to trust the Federal Government with your life.


Independent agency is sought to prevent conflicts of interest

Sabin Russell, Chronicle Medical Writer

Tuesday, November 23, 2004

The Journal of the American Medical Association, citing the slow pace of drug recalls after evidence turns up lethal side effects, called Monday for the creation of an independent agency to monitor the safety of pharmaceuticals once they come to market.

The call for more nimble “post-marketing” surveillance was prompted by a spate of recent drug failures such as the arthritis pill Vioxx and cholesterol- lowering Baycol, both of which were pulled off the market long after studies showed they could be dangerous.

In a sternly worded editorial released in advance of its Dec. 1 publication, the prestigious medical journal suggested that inherent conflicts of interest among industry researchers had led to suppression of study findings that were unfavorable to the companies for whom they worked.

Posted by SPN on 11/23 at 02:55 PM in Blogging

The trackback URL for this entry is: M20o93H7pQ09L8X1t49cHY01Z5j4TT91fGfr


M30o93H7pQ09L8X1t49cHY01Z5j4TT91fGfr M40o93H7pQ09L8X1t49cHY01Z5j4TT91fGfr


M50o93H7pQ09L8X1t49cHY01Z5j4TT91fGfr M60o93H7pQ09L8X1t49cHY01Z5j4TT91fGfr M70o93H7pQ09L8X1t49cHY01Z5j4TT91fGfr
M80o93H7pQ09L8X1t49cHY01Z5j4TT91fGfr M90o93H7pQ09L8X1t49cHY01Z5j4TT91fGfr

<< Back to main